Anne E. White - 10 Feb 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role: EVP & Pres, Lilly Neuroscience
Signature: /s/ Jonathan Groff for Anne E. White, pursuant to authorization on file
Issuer symbol: LLY
Transactions as of: 10 Feb 2023
Net transactions value: +$1,231,842
Form type: 4
Filing time: 14 Feb 2023, 16:12:35 UTC
Previous filing: 03 Feb 2023
Next filing: 02 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LLY	Common Stock	Award	$2,954,917	+8,562	+16%	$345.12	62,926	10 Feb 2023	Direct
transaction	LLY	Common Stock	Sale	$856,900	-2,500	-4%	$342.76	60,426	10 Feb 2023	Direct	F1
transaction	LLY	Common Stock	Sale	$866,175	-2,500	-4.1%	$346.47	57,926	13 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LLY	Restricted Stock Unit	Award	$0	+4,124		$0.000000	4,124	10 Feb 2023	Common Stock	4,124		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2022.
F2	Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.